Clinical Trial Update: Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of agomelatine in patients with obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: COMPLETED